Abstract
The effects of the nonselective phosphodiesterase (PDE) inhibitor 3-isobutyl-1-methylxanthine (IBMX) and the selective PDE inhibitors motapizone (type III), rolipram (type IV), zardaverine (type III/IV), and zaprinast (type V and I) on prostaglandin F2 alpha (PFG2 alpha)-induced tone in human pulmonary arteries was investigated. Relaxation was achieved by IBMX [concentration eliciting 50% of maximum response (EC50): 11.3 microM, n = 10], motapizone (EC50:3.0 microM, n = 7), zardaverine (EC50: 3.2 microM, n = 9), and zaprinast (EC50: 31.8 microM, n = 6), whereas rolipram was almost ineffective. The combination of motapizone and zaprinast (10 microM) was the most effective relaxant with supra-additive relaxation and a motapizone EC50 of 575 nM. Biochemical studies revealed the presence of the PDE isozymes I, III, IV and V in the cytosolic and particulate phases of arterial homogenates; PDE II was not detectable. Partial inhibition of adenosine 3',5'-cyclic monophosphate (cAMP)-hydrolyzing PDE activity was achieved with rolipram (26 +/- 2.2%) or motapizone (60 +/- 5.4%), whereas there was almost complete inhibition of total PDE activity with zardaverine (81 +/- 2.0%) or the combination of motapizone and rolipram (82 +/- 2.3%). Inh...Continue Reading
Citations
Aug 25, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·H SchütteF Grimminger
Aug 21, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·Inja LimGianrico Farrugia
Nov 15, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·Oleg V EvgenovFumito Ichinose
Mar 27, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·William J PerkinsKeith A Jones
Apr 9, 2005·American Journal of Respiratory and Critical Care Medicine·John WhartonMartin R Wilkins
Dec 21, 2000·American Journal of Physiology. Heart and Circulatory Physiology·R H SteinhornJ R Fineman
Sep 21, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Peter G PhillipsNicholas W Morrell
Feb 27, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Akihito SasakiHiroshi Azuma
Feb 9, 2012·Experimental Biology and Medicine·Birgit HouwelingDaphne Merkus
Oct 4, 2003·American Journal of Respiratory and Critical Care Medicine·Takefumi ItohHiroshi Kimura
Feb 4, 2006·Cardiology in the Young·Astrid E LammersChristine M Pierce
Apr 5, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Siobhán B TarpeyMary I Townsley
Nov 8, 2001·American Journal of Physiology. Cell Physiology·K D KeefJ Zhong
May 25, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Olivier PauvertJean-Pierre Savineau
Jul 28, 2011·Neonatology·Candice D FikeJane A Madden
Nov 13, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·R T SchermulyD Walmrath
Feb 13, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·M Oka
Feb 1, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·B LarrueL Storme
Mar 16, 2021·Terapevticheskiĭ arkhiv·A A Shmalts, S V Gorbachevsky